Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results

por Süha, Çetin, Mustafa Gökhan, Vural, Ekrem, Yeter, Mehmet, Doğan, Göksal, Keskin, Mehmet Akif, Öztürk
Publicado 2014